Get notified when HAE files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: HAE HAEMONETICS CORP 8-K

Haemonetics restructures reporting segments, merging Plasma and Blood Center into Apheresis

Filed June 5, 2026 · Period ending June 5, 2026 · ~1 min read

Key Changes

  • medium

    Effective Q1 fiscal 2027, Haemonetics will combine its Plasma and Blood Center segments into a single Apheresis segment and rename Hospital to MedSurg, aligning external reporting with internal management structure.

    Item 8.01 view on EDGAR →
  • medium

    Company posted nine quarters of historical financials (Q1 FY2024-Q4 FY2026) restated under the new segment structure to enable year-over-year comparisons going forward.

    Item 8.01 view on EDGAR →
  • medium

    Fiscal 2027 guidance has been recast into the new segment framework but is not being reaffirmed or updated; actual guidance updates expected during Q1 FY2027 earnings call.

    Item 8.01 view on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ISNR 10-Q) is open in full — no account needed.

Partner

Trade HAE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify